DC

Dhruba Charan Pattanaik

Active Director Director DIN 01403965
DIN 01403965 First appointment Apr 1996 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 1996
Shareholding value β€’β€’β€’β€’ Premium profile

About Dhruba Charan Pattanaik

Data last updated:

Dhruba Charan Pattanaik is a Director at Reeta Clinic Diagnostic And Research Centre Pvt Ltd (since 1996). The company operates in Healthcare.

DIN 01403965
Primary Designation Director
Industry Healthcare
First Appointment 11 Apr 1996
Oldest Company Age 40 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Apr 19961986Active

Board colleagues of Dhruba Charan Pattanaik

Directorship timeline

Open interactive timeline →
Reeta Clinic Diagnostic And Research Centre Pvt Ltd
Premium access

Shareholding and investment profile for Dhruba Charan Pattanaik

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dhruba Charan Pattanaik

Dhruba Charan Pattanaik currently holds 1 directorship: Reeta Clinic Diagnostic And Research Centre Pvt Ltd (Director, since 11 Apr 1996).

Dhruba Charan Pattanaik was first appointed on 11 Apr 1996 as Director at Reeta Clinic Diagnostic And Research Centre Pvt Ltd.

The current boards of Dhruba Charan Pattanaik's companies include Deepayan Pattnaik (Reeta Clinic Diagnostic And Research Centre Pvt Ltd), Reeta Mohanty (Reeta Clinic Diagnostic And Research Centre Pvt Ltd).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available